Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Mushroom Wisdom, Inc.
WARNING LETTER
•Mushroom Wisdom, Inc.•January 1, 2012

Mushroom Wisdom, Inc. – FDA Warning Letter, Jan 1, 2012

Record Details

The FDA issued a Warning Letter to Mushroom Wisdom, Inc. after reviewing their website (www.mushroomwisdom.com) in January 2012 and promotional materials collected on September 23, 2011, at the Natural Products ExpoEast trade show. The FDA determined that the "Maitake D-Fraction," "Maitake SX-Fraction," and "Brain-Mate" products are promoted for conditions that classify them as drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321 (g)(1)(B)].

The claims on the website and in promotional materials establish these products as drugs intended for the cure, mitigation, treatment, or prevention of disease, violating the Act. Examples of claims include "Maitake D-Fraction Induces Apoptosis in Breast Cancer Cells," "Maitake SX-Fraction...including insulin resistance linked to...Type 2 diabetes," and "Hericenones...have great potential for...preventing and treating Alzheimer's disease" for Brain-Mate. Metatags like "Cancer Fighting" also contribute to these claims.

These products are considered "new drugs" under section 201(p) of the Act [21 U.S.C. § 321(p)] because they are not generally recognized as safe and

Company
Mushroom Wisdom, Inc.
Inspection date
January 1, 2012
Product type
Drugs
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · b4b4b478-c12a-48eb-a2e6-717f8d76fa78

Violation Codes5
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Other documents for Mushroom Wisdom, Inc.
  • WARNING_LETTER - 2012-04-30April 30, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mushroom Wisdom, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.